这种多功能化合物是内皮抑制素，一种抑制血管生成，即身体内新血管生长的人体蛋白质。
The versatile compound is endostatin, a human protein that inhibits angiogenesis, the growth of new blood vessels in the body.
恶性肿瘤的生长具有血管生成依赖性。
血管生成是一种生理过程，新血管从现有血管长出。
Angiogenesis is a physiological process whereby new blood vessels grow from existing vessels.
它们与肿瘤的血管生成和成熟密切有关。
They are closely associated with angiogenesis and vessel maturation of tumor.
治疗性血管生成是近年来提出的新概念。
The concept of therapeutic angiogenesis is defined in recent years.
血管生成抑制剂可以阻止肿瘤生成血管。
Angiogenesis inhibitors prevent the tumors from creating blood vessels.
血管生成是恶性肿瘤生长和转移的基础。
Angiogenesis is the basis of growth and metastasis of malignant tumor.
内源性血管生成抑制剂可作为一种抑癌蛋白。
Endogenous angiogenesis inhibitors act as tumor suppressor proteins.
肿瘤血管生成与肿瘤的发生和转移密切相关。
Tumor angiogenesis plays an important role in tumor growth and metastasis.
聚糖能调节肿瘤增殖、侵袭、转移和血管生成。
Glycans regulate tumour proliferation, invasion, haematogenous metastasis and angiogenesis.
醋酸甲羟孕酮抑制血管生成的影响所致恶性肿瘤。
Inhibitory effect of medroxyprogesterone acetate on angiogenesis induced by malignant neoplasm.
VEGF和其受体结合在血管生成中起重要作用。
There is very important binding VEGF with its receptors in angiogenesis.
血管生成是影响肿瘤生物学行为的重要因素之一。
The blood vessel production affects one of tumor biology behavior important attributes.
血管生成是肿瘤生长、侵袭、转移、和复发的基础。
Angiogenesis is the basis of tumor growth, invasion, metastasis and recidivism.
肿瘤血管生成在肿瘤的生长和转移中起着重要的作用。
Tumor associated angiogenesis plays a pivotal role in the growth and metastasis of tumors.
与肿瘤血管生成相关的调控基因的研究也越来越受到重视。
And the genes involved in the regulation of tumor angiogenesis play an increasingly important role in the field of tumor researches.
探讨胃癌动态增强MRI强化表现与肿瘤血管生成的关系。
To investigate the correlation between the dynamic MRI enhancement characteristics and tumor angiogenesis in gastric carcinoma.
癌基因突变引起肿瘤形成，而血管生成则是肿瘤扩大所必需的。
Oncogenic mutations initiate tumorigenesis but angiogenesis is necessary for expansion of tumor mass.
血管生成素的核糖核酸酶活性很弱，但对它的血管生成活性是至关重要的。
Although the catalytic activity of angiogenin is rather weak, it is critical for its angiogenic properties.
此外，一些血管生成抑制剂已被FDA批准作为治疗癌症或眼内新生血管性疾病。
In addition, several angiogenesis inhibitors have been approved by the FDA as therapy for cancer or intraocular neovascular disorders.
PET可以早期准确地反映肿瘤相关生物特征，如血管生成、凋亡、乏氧和增殖等。
The relative biological features as angiogenesis, apoptosis, hypoxic and proliferation can be reflected by PET early and correctly.
其他的讨论将集中于在治疗性血管生成的新的组织工程干细胞为基础的方法的兴趣。
Additional discussion will focus on a renewed interest in therapeutic angiogenesis by tissue engineering or stem cell-based approaches.
目的研究大肠癌与转移癌组织的血管生成情况，探讨血管生成与肿瘤转移和预后的关系。
Objective To explore the relationship between angiogenesis and tumor metastasis and prognosis by studying the angiogenesis in colorectal carcinoma tissues and metastasized tissues.
肿瘤血管生成抑制剂是一类能破坏或抑制血管生成，有效地阻止肿瘤生长和转移的药物。
Tumor angiogenesis inhibitor is a class of new drugs that can destroy or inhibit tumor neovascularization, and can effectively block the growth and metastasis of cancer.
这个过程是一个身体增长和愈合能力正常功能的一部分，而肿瘤从良性向恶性转变也是通过血管生成。
Although this process is a normal part of the body's ability to grow and heal itself, angiogenesis is also the path through which tumors transition from benign to malignant.
还有证据表明，各种基质细胞在正常和病理的血管生成在一个组织或上下文特定的方式参与。
There is also evidence that various stromal cell types participate in normal and pathological angiogenesis in a tissue - or context-specific fashion.
局部血管生成治疗使用重组人碱性成纤维细胞生长因子，这项技术已经应用到促进伤口愈合中。
Local angiogenic therapy with recombinant human basic fibroblast growth factor has been used to promote wound healing.
然而在众多的血管生成因子中，血管内皮细胞生长因子(VEGF)是最有力的血管生成因子。
But in many vascular growth factors, vascular endothelial cell growth factor (VEGF) is the most important vascular growth factor.
然而在众多的血管生成因子中，血管内皮细胞生长因子(VEGF)是最有力的血管生成因子。
But in many vascular growth factors, vascular endothelial cell growth factor (VEGF) is the most important vascular growth factor.
应用推荐